SCHEMBL8772476

SCHEMBL8772476

COc1ccc(S(=O)(=O)C2CC(=O)N2CCCCCCc2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
HSD17B10 Q99714 1/20 0.46
POLB P06746 3/20 0.45
TSHR P16473 2/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
SIGMAR1 Q99720 1/20 0.44
MAPT P10636 1/20 0.43
OPRM1 P35372 1/20 0.43
MMP1 P03956 2/20 0.43
MMP9 P14780 1/20 0.43
MMP13 P45452 1/20 0.43
ADAM17 P78536 1/20 0.43
SSTR5 P35346 1/20 0.42
MMP3 P08254 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KCNA5 P22460 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8772491 0.81 HTR2A (0.42) ALDH1A1POLBSIGMAR1TDP1L3MBTL1
SCHEMBL8104154 0.79 FAAH (0.44) POLBTSHRCYP3A4CYP2D6CYP2C19
SCHEMBL8772509 0.77 TSHR (0.44) ALDH1A1HSD17B10POLBTSHRCYP3A4
SCHEMBL8772533 0.77 KCNA5 (0.42) ALDH1A1TSHRCYP3A4CYP2C9CYP2C19
SCHEMBL8439355 0.77 GSK3A (0.44) ALDH1A1TSHRCYP3A4CYP2D6CYP2C19
SCHEMBL8441542 0.75 ALDH1A1 (0.52) ALDH1A1POLBKCNA5KCNH2
SCHEMBL14609253 0.75 OPRK1 (0.57) ALDH1A1POLBTSHRCYP3A4CYP2D6
SCHEMBL6820212 0.72 MMP8 (0.60) ALDH1A1HSD17B10POLBMMP1MMP13
SCHEMBL8772449 0.71 CYP1A2 (0.42) ALDH1A1POLBCYP3A4CYP2D6CYP2C9
SCHEMBL8772454 0.71 POLB (0.42) ALDH1A1POLBSIGMAR1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799200-A1 SUBSTITUTED AZETIDIN-2-ONES FOR TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-10-08 EP disclosed